Skip to main content

Diagnostic performance of an automated qRT-PCR assay using a peripheral blood host 5-mRNA signature for active tuberculosis: a single-center prospective cohort study and external validation in public databases

In brief

A five-gene blood test detected TB with 84% sensitivity and 95% specificity

In a single-center study, an automated blood test measuring five host mRNAs distinguished active tuberculosis from other infections with 83.6% sensitivity and 95.1% specificity. The signature also separated active from latent tuberculosis across six public datasets, but clinical use as a near-point-of-care test still needs evaluation beyond this cohort.

Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Q1)
Published
17 November 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Xiaocheng Luo, Zhenxing Wang, Xianzhen Huang, Yuliang Huang, Shunda Luo, Jinfeng Lu, et al.
PMID
43044812
DOI
10.1016/j.ijid.2026.109254

Why clinicians should know about it

  • Picked for Microbiology (medical) (paper of the day, 18 November 2026): Automated blood qRT-PCR host signature evaluated for active tuberculosis diagnosis

Abstract

BACKGROUND: Tuberculosis remains a major global public health concern. Current sputum-based etiological assays have limited diagnostic performance in patients with smear-negative tuberculosis, atypical clinical manifestations, or restricted access to specimens containing Mycobacterium tuberculosis (MTB). Novel molecular tools for clinical triage in healthcare settings are urgently needed. METHODS: A total of 438 participants were enrolled and classified into five groups based on comprehensive clinical data: confirmed active tuberculosis (Group 1), suspected tuberculosis after antibiotic treatment (Group 2), undetermined diagnosis (Group 3), non-tuberculous infectious disease controls (Group 4), and non-infectious controls (Group 5). mRNA expression levels of FCGR1A, FCGR1B, GBP5, GBP6, and CXCL10 in peripheral blood were measured, and the TB active score (TBA-Score) was calculated to identify TB infection. Multiple public microarray and RNA-seq datasets were used for external validation of the diagnostic performance of this 5-host-gene signature for tuberculosis infection. RESULTS: The TBA-Score was significantly elevated in patients with active tuberculosis and effectively discriminated active tuberculosis from non-tuberculous infectious and non-infectious controls. The AUC for Group 1 versus Group 4 was 0.905 (95% CI, 0.850-0.959), with a sensitivity of 83.6% and specificity of 95.1%; the AUC for Group 1 versus Group 5 was 0.916 (95% CI, 0.869-0.962), with a sensitivity of 83.6% and specificity of 90.6%. During external validation, this 5-mRNA signature retained robust discriminative ability across six public transcriptomic datasets, with AUC values ranging from 0.824 to 0.970 for distinguishing active tuberculosis from latent tuberculosis infection. CONCLUSIONS: This automated qRT-PCR system enables rapid detection using peripheral-blood-derived 5-mRNA TBA-Score. The signature shows cross-platform and multi-ethnic population reproducibility, supporting its further evaluation for non-sputum near-point-of-care TB testing.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.